Cardiologist at @DukeHeartCenter
Durham, NC
Joined September 2011
- Tweets59
- Following51
- Followers332
- Likes256
Christopher Granger retweeted
White paper on advancing #implementation of #CKM therapies led by @NkiruOsude @cbgranger et al in @AmericanHeartJ
Wonderful to see seasoned implementation scientists or investigators who’ve led high-touch implementation RCTs / projects on author panel.
sciencedirect.com/science/ar…
Christopher Granger retweeted
When cardiovascular medicines should be discontinued
- for the prevention of potential harm
- for a lack of benefit
- for the availability of better alternatives.
Our #deprescribing review has just been published in @ESC_Journals @cbgranger @DCRINews
doi.org/10.1093/eurheartj/eh…
Christopher Granger retweeted
Tour de force @DukeCardiology Grand Rounds by @thiele_holger on “Cardiogenic Shock Treatment- Between Clinical Practice and Current Evidence.” @DukeHeartCenter @DukeHrtFailure @DukeMedSchool @manesh_patelMD @JasonKatzMD @jennifer_rymer @Nishant_ShahMD
Christopher Granger retweeted
Fantastic talk! Itd all about the first 10 minutes!
Impressive presentation by Enrico Baldi about the importance of lay response in #CPR
⚠️ New proposed chain of survival including people involved
Time matters in CPR 🫀🫀🫀🧠🧠🧠 #ACVC2023 @erc_young @ERC_resus @AbdoKhoury00 @GSoCers @AwadZei1
Christopher Granger retweeted
ACC 23 Late-breaking Discussion with @NPagidipati & @cbgranger:COORDINATE-Diabetes Trial
Multifaceted intervention⬆️prescription of 3 groups of evidence-based therapies
Publication: ja.ma/3ZkfIbM
#LBCT #ACC23 #WCCardio #laSECtelleva #DIabetes
youtu.be/LxXeTg0SBdY
Christopher Granger retweeted
#ACC23 🔥Late-breaking Discussion
Join Drs @hvanspall, @NPagidipati & @cbgranger as they discuss the #COORDINATE-Diabetes trial👉 ow.ly/9iij50N9Ftu
Coordinated, multifaceted intervention ⬆️ prescription of 3 groups of evidence-based therapies in adults with #T2DM & #ASCVD
Christopher Granger retweeted
Learning about so many exciting advances in #HeartFailure at the #BeaverCreekCardiovascular conference. #HFGuidelines #cardiacamyloid new devices #xenotransplantation and more! @robmentz @DukeCardiology @BeaumontCards
Christopher Granger retweeted
RNA-targeted therapeutics in CVD: the time is now!
We tried to provide an update on several exciting developments in the field of RNA-targeted therapeutics in CVD - focus on lipids, anticoagulation, TTR amyloidosis and hypertension. #siRNA #ASO
academic.oup.com/ehjcvp/adva…
Christopher Granger retweeted
We just made it! #ECLS-SHOCK last patient in just happened!!! Congrats to the whole team! Another milestone in #cardiogenicshock treatment! @AGIKinterv @KardiologieHH @TRassafMD @YoungDgk @DGK_org @AnneFreund3 @hvanspall
Christopher Granger retweeted
Time to treatment in STEMI is critical and we are not meeting our goals! We need to refocus efforts! ja.ma/3zO4Zf7 via @JAMA_current part of @JAMANetwork. Congrats to Dr Jamie Jollis & @cbgranger @AKjacobsBUMC on this study. Proud to be part of such an amazing team!
Christopher Granger retweeted
Just arrived in Chicago for #AHA22. Easy trip from Durham & nice to catch up w friends in the Uber. Caught a glimpse of @DCRINews booth. Early checkin & time for a run before meetings start
@AHAScience @cbgranger @manesh_patelMD @DukeHeartCenter
Christopher Granger retweeted
#Duke Cardiology researchers team up with North Carolina emergency care personnel across the state in a pragmatic cluster-randomized trial, RACE-CARS, that willI test community interventions to improve survival for out of hospital cardiac arrest
Read: tinyurl.com/yjfzwn56
ALT RACE-CARS trial
Christopher Granger retweeted
Best of 2022 in Acute Cardiovascular Care!
- Nov 24
- 16:00 - 20:00 CET
We will review the best of #AHA22, #ACC22, #ACVC2022 and #ESCCongress!
Who: @cbgranger @sighalvo @AbdoKhoury00 @ASionis @VranckxPascal @Drroxmehran, @docclemme, myself and others!
escardio.org/Sub-specialty-c…
Christopher Granger retweeted
Great presentation by @JLHarrington_MD with individual patient data from COMBINE-HF. The news: NOAC’s safe and effective in patients with AF and reduced renal function. #ACC22 @DukeCardFellows @manesh_patelMD
Christopher Granger retweeted
“Gaps in care are not the exception, they are the rule” - @cbgranger 🤯
Let’s change that, shall we? Starting now. 🏃🏾♀️⏰ #ImplementationWorks
#Treat2BeatCIEDInfection❤️🩹
@RizwanSohailMD @cbgranger @sean_pokorney @ElaineWanMD @BruceWilkoff @AHAScience @ecoromil @AlexWickMD
Christopher Granger retweeted
I love the Russian people. That is why I have to tell you the truth. Please watch and share.
Christopher Granger retweeted
Currently discussing #ttm (targeted temperature management) / temperature controle at the #acvc2022 with @sarahmperman , @ACVCPresident, @cbgranger and prof. Niklas Nielsen.
Still indication for hypthermia in some subgroups of cardiac arrest-patients? Please join the discussion
Christopher Granger retweeted
New from our team - critical need to reframe SGLT-2i and GLP-1RA as cardiovascular and kidney risk-reducing agents ahajournals.org/doi/10.1161/…
Christopher Granger retweeted
Watching the great discussion by @perkins_gd @proftomquinn @cbgranger @KeithCouper and Jan Belohlavek at this @escardio #ACVC2021 joint session with @EuroELSO and @ERC_resus
Christopher Granger retweeted
In this RCT, discontinuing ACEIs or ARBs when hospitalized with mild to moderate COVID-19 did not result in a difference in the mean number of days alive and out of the hospital vs continuing the drugs @RenatoDLopes1 @DukeMedSchool ja.ma/36iCjMq